id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2016-N-0436-0115,FDA,FDA-2016-N-0436,Attachment 1 Letter from Zoll to WakeMed Raleigh Hospital re: Comment from Dallas Sutton,Supporting & Related Material,Background Material,2016-06-02T04:00:00Z,2016,6,,,2016-06-02T18:29:15Z,,0,0,090000648200aa80
FDA-2016-N-0436-0097,FDA,FDA-2016-N-0436,Attachment 1: Sample FDA Docket re: Comment from Acertara Acoustic Laboratories,Supporting & Related Material,Background Material,2016-06-02T04:00:00Z,2016,6,,,2016-06-02T18:16:30Z,,0,0,090000648200a06c
FDA-2016-N-0436-0135,FDA,FDA-2016-N-0436,Exhibits A-M re: Comment from Karl Storz (Mintz Levin),Supporting & Related Material,Electronic Regulation from Form,2016-06-02T04:00:00Z,2016,6,,,2016-06-02T20:19:37Z,,0,0,090000648200b251
FDA-2016-N-0436-0110,FDA,FDA-2016-N-0436,Attachment B A Collective Risk Model for Health Systems AOs & NCAs re: Comment from Binseng Wang (Cover Letter),Supporting & Related Material,Background Material,2016-06-02T04:00:00Z,2016,6,,,2016-06-02T18:16:30Z,,0,0,090000648200aa1a
FDA-2016-N-0436-0111,FDA,FDA-2016-N-0436,Attachment C Answers to FDA Questions re: Comment from Binseng Wang (Cover Letter),Supporting & Related Material,Background Material,2016-06-02T04:00:00Z,2016,6,,,2016-06-02T18:16:31Z,,0,0,090000648200aa1d
FDA-2016-N-0436-0109,FDA,FDA-2016-N-0436,Attachment A Comments on FDA Proposed Definitions of Third-Party and OEM Activities re: Comment from Binseng Wang (Cover Letter),Supporting & Related Material,Background Material,2016-06-02T04:00:00Z,2016,6,,,2016-06-02T18:16:30Z,,0,0,090000648200a606
FDA-2016-N-0436-0089,FDA,FDA-2016-N-0436,Attachment 1 Consensus Body Approved Draft of ANSI RIC Standard re: Comment from Remanufacturing Industries Council (RIC),Supporting & Related Material,Background Material,2016-06-02T04:00:00Z,2016,6,,,2016-06-02T18:18:17Z,,0,0,090000648200a068
FDA-2016-N-0436-0039,FDA,FDA-2016-N-0436,"Refurbishing, Reconditioning, Rebuilding, Remarketing,  Remanufacturing, and Servicing of Medical Devices Performed by Third-
Party Entities and Original Equipment Manufacturers; Extension of Comment Period",Proposed Rule,Extension of Comment Period,2016-04-25T04:00:00Z,2016,4,2016-04-25T04:00:00Z,2016-06-04T03:59:59Z,2016-06-10T01:00:31Z,2016-09443,0,0,0900006481f88f51
FDA-2016-N-0436-0019,FDA,FDA-2016-N-0436,Attachment 1 Fennigkoh-Managing Medical Equipment Risks re: Comment from Larry Fennigkoh,Supporting & Related Material,Background Material,2016-03-31T04:00:00Z,2016,3,,,2016-03-31T18:35:24Z,,0,0,0900006481eef155
FDA-2016-N-0436-0001,FDA,FDA-2016-N-0436,"Refurbishing, Reconditioning, Rebuilding, Remarketing,  Remanufacturing, and Servicing of Medical Devices Performed by Third-
Party Entities and Original Equipment Manufacturers; Request for  Comments",Proposed Rule,Request for Comment,2016-03-04T05:00:00Z,2016,3,2016-03-04T05:00:00Z,2016-05-04T03:59:59Z,2016-05-06T19:00:24Z,2016-04700,0,0,0900006481ea097a